Meeting
2015 ASCO Annual Meeting
Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).
Authors
Shingo Matsumoto
Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Shingo Matsumoto , Kiyotaka Yoh , Takashi Seto , Takuma Yokoyama , Haruyasu Murakami , Eiji Iwama , Shunichi Sugawara , Yuichiro Ohe , Koji Takeda , Makoto Nishio , Miyako Satouchi , Masato Shingyoji , Daijiro Harada , Takako Okuyama , Norio Okamoto , Takashi Kohno , Koji Tsuta , Genichiro Ishii , Katsuya Tsuchihara , Koichi Goto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 8093)
DOI
10.1200/jco.2015.33.15_suppl.8093
Abstract #
8093
Poster Bd #
417
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Development of nationwide genomic screening project (LC-SCRUM-Japan) contributing to the establishment of precision medicine in Japan.
First Author: Takuma Yokoyama
Poster
2014 ASCO Annual Meeting
Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers.
First Author: Alexander E. Drilon
Poster
2023 ASCO Annual Meeting
A master screening study to determine biomarker status and trial eligibility for patients with malignant tumors.
First Author: Benjamin J. Solomon
Poster
2020 ASCO Virtual Scientific Program
Clinical impact of targetable gene alterations on therapeutic outcomes in stage II/III locally advanced non-small cell lung cancer patients.
First Author: Yoshitaka Zenke